Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 5
2005 11
2006 7
2007 6
2008 6
2009 11
2010 6
2011 6
2012 6
2013 8
2014 7
2015 2
2016 6
2017 5
2018 5
2019 3
2020 3
2021 5
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cserepes M, Nelhűbel GA, Meilinger-Dobra M, Herczeg A, Türk D, Hegedűs Z, Svajda L, Rásó E, Ladányi A, Csikó KG, Kenessey I, Szöőr Á, Vereb G, Remenár É, Tóvári J. Cserepes M, et al. Among authors: vereb g. Cancers (Basel). 2022 May 13;14(10):2407. doi: 10.3390/cancers14102407. Cancers (Basel). 2022. PMID: 35626010 Free PMC article.
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Guti E, Regdon Z, Sturniolo I, Kiss A, Kovács K, Demény M, Szöőr Á, Vereb G, Szöllősi J, Hegedűs C, Polgár Z, Virág L. Guti E, et al. Among authors: vereb g. Cancer Immunol Immunother. 2022 Sep;71(9):2151-2168. doi: 10.1007/s00262-022-03146-z. Epub 2022 Jan 23. Cancer Immunol Immunother. 2022. PMID: 35066605 Free PMC article.
108 results